SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-14-321808
Filing Date
2014-08-26
Accepted
2014-08-26 17:22:10
Documents
5
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-Q d778761d10qa.htm 10-Q/A 24566
2 EX-10.1 d778761dex101.htm EX-10.1 622421
3 EX-31.1 d778761dex311.htm EX-31.1 2682
4 EX-31.2 d778761dex312.htm EX-31.2 2701
5 GRAPHIC g778761ex10_1pg066.jpg GRAPHIC 12521
  Complete submission text file 0001193125-14-321808.txt   670784
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36070 | Film No.: 141065969
SIC: 2834 Pharmaceutical Preparations